Litigation Details for Horizon Medicines LLC v. Alkem Laboratories Ltd. (D. Del. 2018)

Horizon Medicines LLC v. Alkem Laboratories Ltd. (D. Del. 2018)

Docket		Date Filed	2018-07-09
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Defendant	Referred To
Patents	8,067,033; 8,067,451; 8,309,127; 8,318,202; 8,449,910; 8,501,228
Link to Docket	External link to docket

Details for Horizon Medicines LLC v. Alkem Laboratories Ltd. (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2020-08-07	187	Opinion - Memorandum Opinion	infringement of U.S. Patent No. 8,067,033 (“the ’033 patent”) and the ’451 patent. (D.I. 1). Following…construction of one term in U.S. Patent No. 8,067,451 (“the ’451 patent”). The Court has considered the…construction issues concerning the ’033 patent. (D.I. 89.) The ’451 patent is addressed to methods and oral… “It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification	External link to document
2020-11-29	238	Opinion	parties had narrowed the case to U.S. Patent No. 8,067,033 (“the ’033 patent”). 3 Before the Court…Unenforceability and/or Non-Infringement for U.S. Patent Nos. 8,067,033 B2, 8,067,451 B2, 8,309,127 B2, 8,318,202…infringement of U.S. Patent Nos. 8,309,127 (the “’127 patent”), 8,318,202 (the “’202 patent”), 8,449,910 (the…the ’033 patent, and the ’096 publication is only a patent publication, not a granted patent.” (Id.).…asserted patent claims. Horizon asserts infringement of claims 1, 8, 11, and 14 of the ’033 patent. (D.I	External link to document